HPV E6 Knockdown Restores Adenovirus Mediated-Estrogen Response Element Linked p53 Gene Transfer in HeLa Cells
نویسندگان
چکیده
p53 is inactivated and degraded by the E6 protein encoded by the integrated human papillomavirus (HPV) in the cervical cancers (Scheffner et al., 1990). The susceptibility of p53 to degradation by the E6 protein varies between the arginine and proline variants at codon 72 of p53 (Storey et al., 1998). In vivo studies demonstrate that the arginine p53 variant is seven times more susceptible to degradation by the E6 protein, compared with the proline variant (Storey et al., 1998). However, the results of clinical studies are controversial, with the majority of studies demonstrating no significant difference between individuals harboring the arginine or proline p53 variant (Andersson et al., 2001; Klug et al., 2009; Nunobiki et al., 2011; Habbous et al., 2012). We considered that hormonal factors may affect these results. The estrogen response element (ERE) is a DNA sequence (-GGTCAnnnTGACC-) that when bound by the estrogen receptor, leads to the transcriptional activation of target genes (Klinge et al., 2001). We found that the ERE
منابع مشابه
Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Retinoids mediate the normal growth of a variety of epithelial cells and may play an important role in the chemoprevention of breast cancer. Despite the widespread clinical use of retinoids, specific target genes that are regulated by retinoids are relatively poorly characterized. We reported previously that all-trans-retinoic acid (ATRA) mediates G1-S-phase arrest in normal human mammary epith...
متن کاملAdenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
To explore the potential of an adenoviral antisense RNA transcript for gene therapy of cervical cancer, we introduced the antisense RNA transcript of E6 and E7 genes of human papillomavirus (HPV) 16 into cervical cancer cells harboring HPV 16 via a recombinant adenoviral vector, Ad5CMV-HPV 16 AS and analyzed the effects of expression of these genes on cell growth and tumor growth. Ad5CMV-HPV 16...
متن کاملChemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Recent clinical trials comparing concurrent chemotherapy and radiation with radiation alone in cervical cancer have shown that chemoradiation reduces the risk of death by 30-50%. Despite the clinical success, treatment responses at the cellular level are still inadequately explored. A key event in cervical carcinogenesis is the disruption of p53 tumor suppressor pathway by human papillomavirus ...
متن کاملAdenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
OBJECTIVE In most cervical cancers, human papillomaviruses (HPVs) are identified. The E6 and E7 genes of HPVs encode proteins, that interfere with the function of the tumor suppressor proteins p53 and Rb. We are exploring the potential use of antisense HPV RNA transcripts for gene therapy for HPV-positive cervical cancers. METHODS Via a recombinant adenoviral vector, Ad5CMV-HPV 16 AS, we intr...
متن کاملSuppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA.
Cervical cancer is caused by high-risk types of human papillomaviruses (HPV) that encode the E6 and E7 oncogenes. Silencing of E6 gene expression in HPV-positive cell lines by transfection of small interfering RNA (siRNA) with cationic lipids restores the dormant p53 tumor suppressor pathway. Because cationic lipids can also be used for intracytoplasmic delivery of proteins, we tested whether t...
متن کامل